| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Electra Therapeutics, Inc.'s insiders have accumulated 2,666,666 shares worth roughly $40.0M on balance. In the past 30 days, 2 insiders bought and 0 sold. Purchases have clustered in the most recent filings.
Leading the buying is GORDON CARL L (Director, 10% Owner). Notably, 1 of the recent buyer ranks in the top tier of our insider score, which grades how well a person's past trades have anticipated price moves.
ETRA sits in the Biotechnology industry within the Healthcare sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 2.00M | - | +1.33M | |
| 10% | 758.3K | - | +1.33M | |
| Dir | 255.6K | - | - | |
| Other | 85.5K | - | - | |
| Other | 63.7K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 21, 2026 | Orbimed Advisors LLC66 | Director, 10% Owner | Buy | 1,333,333 | $15.00 | $19,999,995.00 | +313.8% | |
| Sep 21, 2026 | Gordon Carl L74 | Director, 10% Owner | Buy | 1,333,333 | $15.00 | $19,999,995.00 | +313.8% |